The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
Open accessAbstract
Objective: Rapid eye movement sleep behavior disorder (RBD) is common in Parkinson disease (PD), but its relationship to the varied neurotransmitter deficits of PD and prognostic significance remain incompletely understood. RBD and cholinergic system degeneration are identified independently as risk factors for cognitive impairment in PD. We aimed to assess the association between cholinergic denervation and symptoms of RBD in PD patients without dementia. Methods: Eighty subjects with PD without dementia (age, 64.6 ± 7.0 years; range, 50–82 years; 60 males, 20 females; mean Montreal Cognitive Assessment Test [MoCA] score, 26.2 ± 2.1; range 21–30) underwent clinical assessment, neuropsychological testing, and [ 11 C]methylpiperidyl propionate acetylcholinesterase and [ 11 C]dihydrotetrabenazine (DTBZ) vesicular monoamine transporter type 2 positron emission tomography (PET) imaging. 11 C3‐Amino‐4‐(2‐dimethylaminomethyl‐phenylsulfaryl)‐benzonitrile (DASB) serotonin transporter PET imaging was performed in a subset of 35 subjects. The presence of RBD symptoms was determined using the Mayo Sleep Questionnaire. Results: Twenty‐seven of 80 subjects (33.8%) indicated a history of RBD symptoms. Subjects with and without RBD symptoms showed no significant differences in age, motor disease duration, MoCA, Unified Parkinson Disease Rating Scale motor scores, or striatal DTBZ binding. Subjects with RBD symptoms, in comparison to those without, exhibited decreased neocortical, limbic cortical, and thalamic cholinergic innervation (0.0213 ± 0.0018 vs 0.0236 ± 0.0022, t = 4.55, p < 0.0001; 0.0388 ± 0.0029 vs 0.0423 ± 0.0058, t = 2.85, p = 0.0056; 0.0388 ± 0.0025 vs 0.0427 ± 0.0042, t = 4.49, p < 0.0001, respectively). Brainstem and striatal DASB binding showed no significant differences between groups. Interpretation: The presence of RBD symptoms in PD is associated with relative neocortical, limbic cortical, and thalamic cholinergic denervation although not with differential serotoninergic or nigrostriatal dopaminergic denervation. The presence of RBD symptoms may signal cholinergic system degeneration. ANN NEUROL 2012;
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553 · cited 1×
“Montreal Cognitive Assessment (MoCA) scores <20 were excluded.(15) The mean MoCA score was 26.”
BackgroundStudies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1×
“5, and 12 in H-Y stage 3.(14) The mean duration of disease was 6.”
BackgroundStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationDistribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Goetz, C. G., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R., Dubois, B., et al. (2007) · Movement Disorders · doi:10.1002/mds.21198 · Cited by 1,404
Chronic Behavioral Disorders of Human REM Sleep: A New Category of Parasomnia
Schenck, C. H., Bundlie, S. R., Ettinger, M. G., & Mahowald, M. W. (1986) · Sleep · doi:10.1093/sleep/9.2.293 · Cited by 1,150
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
Boeve, B. F., Silber, M. H., Saper, C. B., Ferman, T. J., Dickson, D. W., Parisi, J. E., Benarroch, E. E., Ahlskog, J. E., Smith, G. E., Caselli, R. C., et al. (2007) · Brain · doi:10.1093/brain/awm056 · Cited by 957
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Postuma, R. B., Gagnon, J. F., Vendette, M., Fantini, M. L., Massicotte-Marquez, J., & Montplaisir, J. (2009) · Neurology · doi:10.1212/01.wnl.0000340980.19702.6e · Cited by 767
Boeve, B. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05115.x · Cited by 643
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G. (2009) · Neurology · doi:10.1212/01.wnl.0000338632.00552.cb · Cited by 625
REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease
Gagnon, J. F., Bédard, M. A., Fantini, M. L., Petit, D., Panisset, M., Rompré, S., Carrier, J., & Montplaisir, J. (2002) · Neurology · doi:10.1212/wnl.59.4.585 · Cited by 598
The cholinergic system and Parkinson disease
Bohnen, N. I., & Albin, R. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.048 · Cited by 566
Self-citationBohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1745 · Cited by 551
Self-citationThe Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
Reassessment of the structural basis of the ascending arousal system
Fuller, P., Sherman, D., Pedersen, N. P., Saper, C. B., & Lu, J. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22559 · Cited by 465
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease
Kuhl, D. E., Koeppe, R. A., Minoshima, S., Snyder, S. E., Ficaro, E. P., Foster, N. L., Frey, K. A., & Kilbourn, M. R. (1999) · Neurology · doi:10.1212/wnl.52.4.691 · Cited by 387
Self-citationDementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
Hilker, R., Thomas, A. V., Klein, J. C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A. H., Herholz, K., & Heiss, W. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191154.78131.f6 · Cited by 384
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., Ota, T., Asahina, M., Fukushi, K., Kuwabara, S., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab2b58 · Cited by 366
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease
Gagnon, J., Vendette, M., Postuma, R. B., Desjardins, C., Massicotte‐Marquez, J., Panisset, M., & Montplaisir, J. (2009) · Annals of Neurology · doi:10.1002/ana.21680 · Cited by 325
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
Bohnen, N. I., Muller, M. L. T. M., Kotagal, V., Koeppe, R. A., Kilbourn, M. A., Albin, R. L., & Frey, K. A. (2010) · Brain · doi:10.1093/brain/awq079 · Cited by 316
Self-citationDecreased striatal dopaminergic innervation in REM sleep behavior disorder
Albin, R. L., Koeppe, R. A., Chervin, R. D., Consens, F. B., Wernette, K., Frey, K. A., & Aldrich, M. S. (2000) · Neurology · doi:10.1212/wnl.55.9.1410 · Cited by 293
Self-citationBoeve, B. F., Molano, J. R., Ferman, T. J., Smith, G. E., Lin, S.-C., Bieniek, K., Haidar, W., Tippmann-Peikert, M., Knopman, D. S., Graff-Radford, N. R., et al. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.12.009 · Cited by 283
Meyer, J. H. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0709 · Cited by 272
Wilson, J. M., Levey, A. I., Rajput, A., Ang, L., Guttman, M., Shannak, K., Niznik, H. B., Hornykiewicz, O., Pifl, C., & Kish, S. J. (1996) · Neurology · doi:10.1212/wnl.47.3.718 · Cited by 222
Ginovart, N., Wilson, A. A., Meyer, J. H., Hussey, D., & Houle, S. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200111000-00010 · Cited by 209
Serotonin and Parkinson's disease: On movement, mood, and madness
Fox, S. H., Chuang, R., & Brotchie, J. M. (2009) · Movement Disorders · doi:10.1002/mds.22473 · Cited by 175
Treatment of REM sleep behavior disorder with donepezil: A report of three cases
Ringman, J. M., & Simmons, J. H. (2000) · Neurology · doi:10.1212/wnl.55.6.870 · Cited by 162
Shute, C. C. D., & Lewis, P. R. (1966) · Cell and Tissue Research · doi:10.1007/bf00406286 · Cited by 152
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA
Gilman, S., Koeppe, R. A., Chervin, R. D., Consens, F. B., Little, R. J. A., An, H., Junck, L., & Heumann, M. (2003) · Neurology · doi:10.1212/01.wnl.0000073745.68744.94 · Cited by 138
Self-citationSpared Caudal Brainstem SERT Binding in Early Parkinson's Disease
Albin, R. L., Koeppe, R. A., Bohnen, N. I., Wernette, K., Kilbourn, M., & Frey, K. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600599 · Cited by 134
Self-citationRuberg, M., Rieger, F., Villageois, A. P., Bonnet, A. M., & Agid, Y. (1986) · Brain Research · doi:10.1016/0006-8993(86)91401-0 · Cited by 133
Restless legs syndrome in Parkinson's disease
Gómez‐Esteban, J. C., Zarranz, J. J., Tijero, B., Velasco, F., Bárcena, J., Rouco, I., Lezcano, E., Lachen, M. C., Jauregui, A., & Ugarte, A. (2007) · Movement Disorders · doi:10.1002/mds.21624 · Cited by 131
Is REM sleep Behaviour Disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?
Marion, M.-H., Qurashi, M., Marshall, G., & Föster, O. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0629-9 · Cited by 129
Bohnen, N. I., Jolles, J., & Twijnstra, A. (1992) · The Clinical Neuropsychologist · doi:10.1080/13854049208401854 · Cited by 128
Self-citationClinical prediction of Parkinson's disease: planning for the age of neuroprotection
Postuma, R. B., Gagnon, J., & Montplaisir, J. Y. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.174748 · Cited by 126
Abetz, L. N., Arbuckle, R. A., Allen, R. P., García-Borreguero, D., Hening, W. A., Walters, A. S., Mavraki, E., & Kirsch, J. M. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.12.011 · Cited by 126
Task switching deficits associated with Parkinson’s disease reflect depleted attentional resources
Woodward, T. S., Bub, D. N., & Hunter, M. A. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00068-4 · Cited by 125
Brønnick, K., Norwegian ParkWest Study Group, Alves, G. W., Aarsland, D., Tysnes, O., & Larsen, J. P. (2010) · Neuropsychology · doi:10.1037/a0020857 · Cited by 121
Koeppe, R. A., Frey, K. A., Snyder, S. E., Meyer, P., Kilbourn, M. R., & Kuhl, D. E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199910000-00012 · Cited by 112
Self-citationDugger, B. N., Murray, M. E., Boeve, B. F., Parisi, J. E., Benarroch, E. E., Ferman, T. J., & Dickson, D. W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01203.x · Cited by 102
Borght, T. M. V., Sima, A. A. F., Kilbourn, M. R., Desmond, T. J., Kuhl, D. E., & Frey, K. A. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00167-h · Cited by 102
Self-citationKim, Y. K., Yoon, I., Kim, J., Jeong, S., Kim, K. W., Shin, Y., Kim, B. S., & Kim, S. E. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02854.x · Cited by 98
Koeppe, R. A., Frey, K. A., Kume, A., Albin, R. L., Kilbourn, M. R., & Kuhl, D. E. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199709000-00001 · Cited by 90
Self-citationA simple synthesis of [11C]Dihydrotetrabenazine (DTBZ)
Jewett, D. M., Kilbourn, M. R., & Lee, L. C. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00213-2 · Cited by 79
Koeppe, R. A., Frey, K. A., Kuhl, D. E., & Kilbourn, M. R. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199912000-00011 · Cited by 77
Self-citationImaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders
Bohnen, N. I., & Frey, K. A. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0083-6 · Cited by 65
Self-citationSnyder, S. E., Tluczek, L. J. M., Jewett, D. M., Nguyen, T. B., Kuhl, D. E., & Kilbourn, M. R. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00045-6 · Cited by 56
Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease
Nomura, T., Inoue, Y., & Nakashima, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.06.023 · Cited by 46
Chaudhuri, К. R., & Martínez‐Martín, P. (2004) · Neurology · doi:10.1212/wnl.63.8_suppl_3.s17 · Cited by 44
Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia
Schmitt, F. A., Farlow, M. R., Meng, X., Tekin, S., & Olin, J. T. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00182.x · Cited by 32
[Visuospatial learning impairment in Parkinson Disease].
Hernández, I. G., Nieto, A., Barroso, J., & Lorenzo, J. N. (2009) · PubMed · Cited by 26
Challenges in the assessment of dream enactment behavior
Bliwise, D. L. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.02.001 · Cited by 1
Cited by
Boeve, B. F., Silber, M. H., Ferman, T. J., Lin, S. C., Benarroch, E. E., Schmeichel, A. M., Ahlskog, J. E., Caselli, R. J., Jacobson, S., Sabbagh, M., et al. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.015 · Cited by 393
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A., & Burn, D. J. (2014) · Movement Disorders · doi:10.1002/mds.25664 · Cited by 382
Walczak-Nowicka, Ł. J., & Herbet, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179290 · Cited by 335
Chahine, L. M., Amara, A. W., & Videnovic, A. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.08.001 · Cited by 333
Hall, H., Reyes, S., Landeck, N., Bye, C., Leanza, G., Double, K., Thompson, L., Halliday, G., & Kirik, D. (2014) · Brain · doi:10.1093/brain/awu193 · Cited by 302
Metadata
- Authors
- Kotagal, V., Albin, R. L., Müller, M. L. T. M., Koeppe, R. A., Chervin, R. D., Frey, K. A., & Bohnen, N. I.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-04
- Volume
- 71
- Issue
- 4
- Pages
- 560-568
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2004103828
- Cited by
- 253
- References
- 57
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.